Burns & Thermal Injuries
Acute burn classification, eschar management, and advanced biologic dressings for partial- and full-thickness burns to promote rapid re-epithelialization and reduce scarring.
Evidence-based protocols and product selection guides for common chronic wound types.
Not all chronic wounds follow the same biological pathway. Venous leg ulcers, diabetic foot ulcers, and pressure injuries each present unique etiologies, microenvironmental challenges, and regulatory considerations. Effective management requires clinicians to move beyond a one-size-fits-all approach and instead apply targeted biologics that address the specific deficits in the wound bed.
The guides below are designed to help wound care teams quickly identify the key clinical features of each wound type, select the most appropriate amniotic membrane biologic, and apply best practices for documentation, billing, and long-term healing. Whether you are preparing for a value analysis committee review or training new staff, these resources provide a structured, evidence-backed framework.
Acute burn classification, eschar management, and advanced biologic dressings for partial- and full-thickness burns to promote rapid re-epithelialization and reduce scarring.
Management of chronic venous insufficiency, CEAP classification staging, compression therapy integration, and the role of amniotic matrix in persistent VLU cases.
Neuropathic and ischemic wound assessment, offloading protocols, infection control, and advanced biologic application for Wagner grade 1–3 diabetic foot ulcers.
Prevention strategies, staging guidelines, repositioning schedules, and the use of regenerative matrices in stage III and stage IV pressure injuries.
Our clinical team can help you align the right amniotic matrix with your patient population and payer requirements.
Request a Clinical Consult